Top 5 Tech Stocks To Invest In Right Now

I went out on a limb last week, and now it's time to see how that decision played out.

I predicted that Model N (NYSE: MODN  ) would post a smaller loss than analysts were expecting. The provider of revenue management solutions has been a dud since going public nearly a year ago, but one thing it has consistently done is post a smaller deficit than what the pros are forecasting. Wall Street was settling for a loss of $0.12 a share, and Model N sported only $0.03 a share in red ink. The stock soared 19% on Tuesday after the better-than-expected report. I was right. After more than a year of predicting that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average � (DJINDICES: ^DJI  ) , I mixed things up two weeks ago. I simply predicted that the Dow would bounce back after plunging 3.5% and 1.1% over the prior two weeks. I repeated the call this time around, and the Dow responded with a hearty 2.3% gain. I was right.� My final call was for LeapFrog (NYSE: LF  ) to beat Wall Street's income estimates in its latest quarter. The maker of electronic learning toys has been routinely beating Wall Street projections over the past year. I was banking on a repeat performance, but it wasn't to be. LeapFrog merely broke even on a sharper drop in revenue than expected. Analysts had been braced for a profit of $0.14 a share. I was wrong.

Two out of three? I can do better than that. Let me once again whip out my trusty, dusty, and occasionally accurate crystal ball to make three calls that may play out over the next few trading days.

10 Best Insurance Stocks To Invest In 2015: Ophthotech Corp (OPHT)

Ophthotech Corporation, incorporated on January 05, 2007, is a biopharmaceutical company specializing in the development of therapeutics to treat diseases of the eye. The Company�� advanced product candidate is Fovista, which the Company is developing for use in combination with anti-VEGF drugs that represent the current standard of care for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is a serious disease of the central portion of the retina, known as the macula, which is responsible for detailed central vision and color perception. It is characterized by abnormal new blood vessel formation and growth, referred to as neovascularization, which results in blood vessel leakage, retinal distortion and scar formation. If untreated, the progressive retinal damage results in rapid, irreversible and severe vision loss. Wet AMD is the cause of blindness in patients over the age of 55 in the United States and the European Union.

The anti-VEGF market for the treatment of wet AMD consists predominantly of two drugs that are approved for marketing and primarily prescribed for the treatment of wet AMD, Lucentis and Eylea, and off-label use of the cancer therapy Avastin. The use of anti-VEGF drugs has significantly improved visual outcomes for patients with wet AMD who have been treated with these drugs as compared to untreated patients.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Shares of Ophthotech (NASDAQ: OPHT) got a boost, shooting up 25.78 percent to $39.54 after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.

• [By Todd Campbell]

  That leads me to Medivation (NASDAQ: MDVN  ) , Ophthotech (NASDAQ: OPHT  ) , and Portola (NASDAQ: PTLA  ) , three companies with important therapies that may very well be destined to become top sellers.

Top 5 Tech Stocks To Invest In Right Now: PositiveID Corp (PSID)

PositiveID Corporation (PositiveID), incorporated in November 2001, is engaged in developing, marketing and selling radio frequency identification (RFID), systems used for the identification of people in the healthcare market. PositiveID is focused on providing health and security identification tools to protect consumers and businesses, operating in two segments: HealthID and ID Security. The Company�� HealthID segment is focused on the development of four products, which includes the GlucoChip, iglucose, Easy Check and the rapid flu detection system. Its ID Security segment includes the identity security suite of products, sold through its NationalCreditReport.com brand and its Health Link personal health record (PHR) business. In July 2011, it completed the sale of substantially all of the assets of NationalCreditReport.com. On May 23, 2011, the Company acquired all of the interest of MicroFluidic Systems (MicroFluidic). In November 2013, the Company sold its interest in VeriTeQ Corporation (VeriTeQ).

HealthID Segment

PositiveID�� HealthID segment product GlucoChip is a glucose-sensing microchip is developed in conjunction with Receptors LLC (Receptors). Iglucose is a self-contained unit that automatically queries a diabetic user�� data-capable glucometer for blood glucose data and sends that data via encrypted text messaging to the iglucose online database. Easy Check is a non-invasive breath glucose detection system, based on the correlation of acetone in exhaled breath to blood glucose levels. The rapid flu detection system is also developed in conjunction with Receptors. The Company�� HealthID segment also includes the VeriMed system, which uses an implantable passive RFID microchip (the VeriChip) that is used in patient identification applications. Each implantable microchip contains a verification number that is read when it is scanned by its scanner.

ID Security Segment

PositiveID�� NationalCreditReport.com business offers consu! mers a range of identity security products and services primarily on a subscription basis. These services help consumers protect themselves against identity theft or fraud and understand and monitor their credit profiles and other personal information, which include credit reports, credit monitoring and credit scores. The Company has Health Link PHR business.

Healthcare Products

PositiveID�� Healthcare products include the GlucoChip, a product that combines a glucose-sensing microtransponder. The Company has partnered with Receptors to develop an in-vivo glucose sensor to detect glucose levels in the human body. In conjunction with Receptors, the Company has completed Phase I and Phase II development of the glucose-sensing microchip and are in Phase III development. The Easy Check breath glucose test, as of January 31, 2012 is under development, is a non-invasive glucose detection system that measures acetone levels in a patient�� exhaled breath. The iglucose system uses machine to machine technology to automatically communicate a diabetic�� glucose readings to the iglucose online database.

MicroFluidic Systems

MicroFluidic specializes in the production of automated instruments for a range of applications in the detection and processing of biological samples, ranging from rapid medical testing to airborne pathogen detection for homeland security. MicroFluidic�� substantial portfolio of related to sample preparation and rapid medical testing applications are the portfolio of virus detection and diabetes management products.

Identity Security Products and Services

National Credit Report.com, LLC (NCRC) is engaged in the consumer provision of credit reports, credit score and credit monitoring products. This business provides a medium for consumers to retrieve and review their credit history, as well as monitor their credit files with one or all three of the major credit reporting bureaus: Experian, Equifax and TransUni! on. The C! ompany�� products and services are offered to consumers on a monthly subscription basis.

Health Link Personal Health Record and Other Applications

Health Link is a patient-controlled, online repository to store personal health information, such as medications, allergies, family history, previous surgeries, vaccinations and lab results. Health Link also connects the patient to a multitude of customized materials, such as personalized health education and online connectivity to caregivers. Patients can also utilize Health Link to connect with numerous Electronic Medical Record (EMR) systems that are accessible through Microsoft HealthVault and Google Health. In conjunction with Raytheon Microelectronics Espana, the Company developed an eight millimetre microchip, which has functionality that is substantially equivalent to the VeriChip.

Advisors' Opinion:

• [By James E. Brumley]

  Ever heard of PositiveID Corp. (OTCMKTS:PSID)? Most people haven't, so don't worry if it's an unfamiliar name. What's surprising is that PSID is still a little unfamiliar to the masses at this stage of the Ebola game. It's not just a worry that we only have to worry about domestically. It's now spreading within the United States, which is a whole different ball game than preventing it from getting to the United States. This presents a real risk of pandemic spreading within our borders. PositiveID can help.

Top 5 Tech Stocks To Invest In Right Now: Demand Media Inc. (DMD)

Demand Media, Inc. operates as an Internet media and domain services company worldwide. The company focuses on an Internet-based model for the professional creation and distribution of content at scale. It offers content and media, and registrar services. The company�s content and media services include creating media content primarily consisting of text articles and videos, and delivering together with its social media and monetization tools to the company's owned and operated Websites and mobile applications, and network of customer Websites and their mobile applications to publishers, brands, and retailers. Its content and media services are delivered through the company's content and media platform, which includes its content creation studio, social media applications, and a system of monetization tools designed to match content with advertisements. The company deploys its content and media platform to it�s owned and operated Websites, such as eHow.com, LIVESTRONG.CO M, and Cracked.com, as well as to Websites operated by its customers. Its registrar service offering provides domain name registration and related value added services, such as third-party Website security services, identification protection services, Web hosting plans, customizable email accounts, and business listing services to resellers, including small businesses, e-commerce Websites, Internet service providers, Web-hosting companies, and retail consumers. Demand Media, Inc. was founded in 2006 and is headquartered in Santa Monica, California.

Advisors' Opinion:

• [By Wallace Witkowski]

  Demand Media Inc. (DMD) �shares declined 0.3% to $5.84 in light volume after the company said it had accepted the resignation of its chief executive, Richard Rosenblatt, effective Oct. 31.

Top 5 Tech Stocks To Invest In Right Now: Johnson & Johnson(JNJ)

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune me diated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in Ne w Brunswick, New Jersey.

Advisors' Opinion:

• [By Maxx Chatsko]

  Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count). If you discount non-pharmaceutical businesses at Roche and Johnson & Johnson (NYSE: JNJ  ) , then the largest pure-play pharma company in the world is Pfizer (NYSE: PFE  ) . The giant weighs in at more than $200 billion -- nearly $30 billion larger than its next closest competitor -- and has been a stalwart of the industry for many decades. �

• [By Fast Weekly]

  My apologies for all the Buffett quotes this afternoon, but I thought his dry and witty humor would be helpful. �So, going forward I'm continuing to watch and wait for additional good opportunities. �Unilever (UL), Chevron (CVX), Conoco Phillips (COP) and Target (TGT) all look like good candidates going forward. �A fair bit lower Johnson & Johnson (JNJ), Proctor & Gamble (PG) and Pepsico (PEP), also look promising.

• [By Dan Newman]

  The largest holdings in GMO's own Quality Fund include�Johnson & Johnson (NYSE: JNJ  ) ,�Oracle� (NYSE: ORCL  ) , and�Google (NASDAQ: GOOG  ) . All three have profit margins above 15%, worldwide operations, and strong respective moats. For Johnson & Johnson, its scale and name brands like Tylenol and Band-Aid lend it power over competitors. Oracle's advantage comes from the lock-in its customers experience, represented by its near-50% market share in database management. And Google's dominance knows no industry bounds. Its search engine holds a 66% market share in the U.S., while its Android mobile phone platform holds 64% market share of global smartphones.